We induced hyperglycaemia in rats via streptozotocin (STZ) treatment that, with low-dose insulin treatment, was stable and sustained over at least 7 weeks, with little weight loss in the animals (Hulse et al., 2015). The gene discussed is INS; the disease is Hyperglycemia.